Literature DB >> 21411746

Linkage of regulators of TGF-β activity in the fetal ovary to polycystic ovary syndrome.

Nicholas Hatzirodos1, Rosemary A Bayne, Helen F Irving-Rodgers, Katja Hummitzsch, Laetitia Sabatier, Sam Lee, Wendy Bonner, Mark A Gibson, William E Rainey, Bruce R Carr, Helen D Mason, Dieter P Reinhardt, Richard A Anderson, Raymond J Rodgers.   

Abstract

Although not often discussed, the ovaries of women with polycystic ovary syndrome (PCOS) show all the hallmarks of increased TGF-β activity, with increased amounts of fibrous tissue and collagen in the ovarian capsule or tunica albuginea and ovarian stroma. Recent studies suggest that PCOS could have fetal origins. Genetic studies of PCOS have also found linkage with a microsatellite located in intron 55 of the extracellular matrix protein fibrillin 3. Fibrillins regulate TGF-β bioactivity in tissues by binding latent TGF-β binding proteins. We therefore examined expression of fibrillins 1-3, latent TGF-β binding proteins 1-4, and TGF-β 1-3 in bovine and human fetal ovaries at different stages of gestation and in adult ovaries. We also immunolocalized fibrillins 1 and 3. The results indicate that TGF-β pathways operate during ovarian fetal development, but most important, we show fibrillin 3 is present in the stromal compartments of fetal ovaries and is highly expressed at a critical stage early in developing human and bovine fetal ovaries when stroma is expanding and follicles are forming. These changes in expression of fibrillin 3 in the fetal ovary could lead to a predisposition to develop PCOS in later life.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411746      PMCID: PMC3219214          DOI: 10.1096/fj.11-181099

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  48 in total

1.  The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.

Authors:  Thomas B Thompson; Thomas F Lerch; Robert W Cook; Teresa K Woodruff; Theodore S Jardetzky
Journal:  Dev Cell       Date:  2005-10       Impact factor: 12.270

2.  Polycystic ovary syndrome--"A riddle wrapped in a mystery inside an enigma".

Authors:  Vasantha Padmanabhan
Journal:  J Clin Endocrinol Metab       Date:  2009-06       Impact factor: 5.958

3.  Topical application of 17beta-estradiol increases extracellular matrix protein synthesis by stimulating tgf-Beta signaling in aged human skin in vivo.

Authors:  Eui Dong Son; Jin Young Lee; Serah Lee; Mi Sun Kim; Byeong Gon Lee; Ih Seoup Chang; Jin Ho Chung
Journal:  J Invest Dermatol       Date:  2005-06       Impact factor: 8.551

4.  A preliminary report on the implication of RT-PCR detection of DAZ, RBMY1, USP9Y and Protamine-2 mRNA in testicular biopsy samples from azoospermic men.

Authors:  A Friel; J A Houghton; M Glennon; R Lavery; T Smith; A Nolan; M Maher
Journal:  Int J Androl       Date:  2002-02

5.  Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

Authors:  M Urbanek; R S Legro; D A Driscoll; R Azziz; D A Ehrmann; R J Norman; J F Strauss; R S Spielman; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  Disordered follicle development in ovaries of prenatally androgenized ewes.

Authors:  Rachel A Forsdike; Kate Hardy; Lauren Bull; Jaroslav Stark; Lisa J Webber; Sharron Stubbs; Jane E Robinson; Stephen Franks
Journal:  J Endocrinol       Date:  2007-02       Impact factor: 4.286

7.  Developmental programming: deficits in reproductive hormone dynamics and ovulatory outcomes in prenatal, testosterone-treated sheep.

Authors:  A Veiga-Lopez; W Ye; D J Phillips; C Herkimer; P G Knight; V Padmanabhan
Journal:  Biol Reprod       Date:  2007-12-19       Impact factor: 4.285

Review 8.  Polycystic ovary syndrome.

Authors:  Robert J Norman; Didier Dewailly; Richard S Legro; Theresa E Hickey
Journal:  Lancet       Date:  2007-08-25       Impact factor: 79.321

9.  Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.

Authors:  Mark J Prodoehl; Nicholas Hatzirodos; Helen F Irving-Rodgers; Zhen Z Zhao; Jodie N Painter; Theresa E Hickey; Mark A Gibson; William E Rainey; Bruce R Carr; Helen D Mason; Robert J Norman; Grant W Montgomery; Raymond J Rodgers
Journal:  Mol Hum Reprod       Date:  2009-08-19       Impact factor: 4.025

10.  Activin signals via SMAD2/3 between germ and somatic cells in the human fetal ovary and regulates kit ligand expression.

Authors:  Shiona M Coutts; Andrew J Childs; Norma Fulton; Craig Collins; Rosemary A L Bayne; Alan S McNeilly; Richard A Anderson
Journal:  Dev Biol       Date:  2007-12-03       Impact factor: 3.582

View more
  38 in total

Review 1.  Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.

Authors:  Selma F Witchel; Sergio E Recabarren; Frank González; Evanthia Diamanti-Kandarakis; Kai I Cheang; Antoni J Duleba; Richard S Legro; Roy Homburg; Renato Pasquali; Rogerio A Lobo; Christos C Zouboulis; Fahrettin Kelestimur; Franca Fruzzetti; Walter Futterweit; Robert J Norman; David H Abbott
Journal:  Endocrine       Date:  2012-06-04       Impact factor: 3.633

2.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

Review 3.  Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions.

Authors:  Rodolfo C Cardoso; Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Neuroendocrinology       Date:  2015-04-01       Impact factor: 4.914

Review 4.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

Review 5.  Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  J Mol Endocrinol       Date:  2018-10-16       Impact factor: 5.098

Review 6.  The role of TGF-β in polycystic ovary syndrome.

Authors:  Nazia Raja-Khan; Margrit Urbanek; Raymond J Rodgers; Richard S Legro
Journal:  Reprod Sci       Date:  2013-04-12       Impact factor: 3.060

Review 7.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 8.  Genetics of the polycystic ovary syndrome.

Authors:  Gülüm Kosova; Margrit Urbanek
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

Review 9.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 10.  Nonhuman primate models of polycystic ovary syndrome.

Authors:  David H Abbott; Lindsey E Nicol; Jon E Levine; Ning Xu; Mark O Goodarzi; Daniel A Dumesic
Journal:  Mol Cell Endocrinol       Date:  2013-01-29       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.